1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
GLOBAL VARICELLA LIVE VACCINE MARKET FORECAST 2020-2028

GLOBAL VARICELLA LIVE VACCINE MARKET FORECAST 2020-2028

  • February 2020
  • 169 pages
  • ID: 5843605
  • Format: PDF
  • By Inkwood Research

Summary

Table of Contents

KEY FINDINGS
The global varicella live vaccine market is estimated to grow and record a CAGR of 5.78% during the forecast period of 2020-2028. The factors fueling the market growth are the rise in the awareness of varicella live vaccine usage, a major boost in the acceptance of varicella vaccines, and active participation of government in immunization programs.

MARKET INSIGHTS
The varicella live vaccines help to build immunity against the varicella-zoster virus, which can cause serious diseases like chickenpox and herpes zoster.Immunization with varicella live vaccines is an effective method to prevent these diseases.

These vaccines are categorized mainly in two types, such as combination and monovalent.
One of the important factors propelling market growth is a boost in immunization programs across the globe.Active government initiatives and continuous efforts to ensure immunization boosts the varicella live vaccine market growth.

In addition, there is a soaring increase in awareness regarding the usage of varicella vaccines in developing countries like India, owing to the presence of programs that discuss vaccines and vaccination.However, high monetary inputs associated with the production of the product hinders the growth of the market.

There is intense competition in the market among Merck & Co. Inc., Sanofi, and Takeda Pharmaceutical Company Limited, which are the major shareholders in the market.

REGIONAL INSIGHTS
The global varicella live vaccine market is geographically analyzed on the basis of the markets situated across the regions of North America, Europe, Asia Pacific, and the Rest of the World.As of 2019, the region of North America accounted for the largest market share in terms of revenue and continues the trend towards the end of the projected period.

This is attributed to the easy availability of the varicella vaccines and the presence of the leading companies in the market, among other factors.The Asia Pacific region is predicted to register the highest growth rate in terms of revenue.One of the primary reasons is a surge in the availability of improved healthcare services.

COMPETITIVE INSIGHTS
Merck & Co., Inc., Bio-Med Pvt. Limited, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, etc. are some of the principal companies operating in the market which have a global presence.

Our report offerings include:
•Explore key findings of the overall market
•Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
•Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
•Market Segmentation cater to a thorough assessment of key segments with their market estimations
•Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
•Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
•Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
•Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. BIO-MED PVT. LIMITED
2. CHANGCHUN BCHT BIOTECHNOLOGY CO. LTD.
3. GREEN CROSS HOLDINGS (GC PHARMA)
4. EMCURE PHARMACEUTICALS LIMITED (ZUVENTUS HEALTHCARE LTD.)
5. EMERGENT BIOSOLUTIONS INC.
6. GLAXOSMITHKLINE PLC
7. MERCK & CO. INC.
8. MITSUBISHI CHEMICAL HOLDINGS CORPORATION (MITSUBISHI TANABE PHARMA CORPORATION)
9. NOVAVAX INC.
10. NOVO MEDI SCIENCES PVT. LTD.
11. SANOFI
12. TAKEDA PHARMACEUTICAL COMPANY LIMITED

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
15% Off

($2500)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Cholera - Pipeline Review, H1 2020

  • $ 2000
  • January 2020
  • 63 pages

Cholera - Pipeline Review, H1 2020SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Cholera - Pipeline Review, H1 2020, provides an overview of the Cholera (Infectious Disease) pipeline ...

Plague - Pipeline Review, H1 2020 $ 2000 January 2020


ref:plp2020

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on